| # | Drug | Count |
|---|---|---|
| 0 | GEMCITABINE HYDROCHLORIDE | 141 |
| 1 | DOCETAXEL | 120 |
| 2 | DOCETAXEL ANHYDROUS | 120 |
| 3 | GEMCITABINE | 102 |
| 4 | CARBOPLATIN | 91 |
| 5 | TRASTUZUMAB | 83 |
| 6 | PACLITAXEL | 70 |
| 7 | CISPLATIN | 68 |
| 8 | CAPECITABINE | 61 |
| 9 | FLUOROURACIL | 55 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMIFOSTINE | 4 | 0.0049 |
| 1 | TIRBANIBULIN | 1 | 0.0040 |
| 2 | CAPSICUM ANNUUM, CETRARIA ISLANDICA, FUCUS VESICULOSUS, GLANDULA SUPRARENALIS SUIS, THYROIDINUM (SUIS), CADMIUM IODATUM, HYDRANGEA ARBORESCENS, PHOSPHORICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), STRONTIUM CARBONICUM, URANIUM NITRICUM, X-RAY | 4 | 0.0039 |
| 3 | IXABEPILONE | 4 | 0.0038 |
| 4 | GEMCITABINE HYDROCHLORIDE | 141 | 0.0026 |
| 5 | SELEGILINE | 7 | 0.0023 |
| 6 | VINORELBINE | 14 | 0.0020 |
| 7 | ENTACAPONE | 8 | 0.0019 |
| 8 | DOCETAXEL | 120 | 0.0018 |
| 9 | DOCETAXEL ANHYDROUS | 120 | 0.0018 |
| # | Drug class | Count |
|---|---|---|
| 0 | Microtubule Inhibitor [EPC] | 189 |
| 1 | Platinum-based Drug [EPC] | 189 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 103 |
| 3 | HER2/neu Receptor Antagonist [EPC] | 83 |
| 4 | Corticosteroid [EPC] | 76 |
| 5 | Alkylating Drug [EPC] | 72 |
| 6 | Kinase Inhibitor [EPC] | 71 |
| 7 | Aromatase Inhibitor [EPC] | 59 |
| 8 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 38 |
| 9 | Topoisomerase Inhibitor [EPC] | 35 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Monoamine Oxidase Inhibitor [EPC] | 7 | 0.0023 |
| 1 | Catechol-O-Methyltransferase Inhibitor [EPC] | 8 | 0.0016 |
| 2 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 9 | 0.0014 |
| 3 | Actinomycin [EPC] | 3 | 0.0014 |
| 4 | Microtubule Inhibitor [EPC] | 189 | 0.0011 |
| 5 | HER2/neu Receptor Antagonist [EPC] | 83 | 0.0011 |
| 6 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 7 | Platinum-based Drug [EPC] | 189 | 0.0007 |
| 8 | Aromatase Inhibitor [EPC] | 59 | 0.0005 |
| 9 | Nonergot Dopamine Agonist [EPC] | 8 | 0.0005 |